法搜网--中国法律信息搜索网
国家食品药品监督管理局药品安全监管司关于举办世界卫生组织疫苗预认证申报程序培训班暨疫苗生产企业座谈会的通知

  □ No
  □ Yes

  Q6: It the answer to the previous question is yes, please provide the names of the countries that inspected your company in the last 5 years.

  Q7: Does the company have a vaccine quality complaints department?
  □ No
  □ Yes
  Q8. Please list in which aspects of GMP you consider your company requires additional training
  □ Process Validation
  □ Documentation control
  □ Equipment Validation
  □ Environmental monitoring
  □ Method validation
  □ Change control
  □ Other

  V. Nonclinical studies

  Q1: Has your company ever sponsored/conducted nonclinical studies?
  □ No
  □ Yes

  Q2: If yes, where were these studies conducted? (more than one answer allowed)
  □ company's own facility
  □ contractor's facility (e.g. university; Contract Research Organization [CRO]
  □ other  Specify:_______________________________________________

  VI. Clinical trials

  Q1: Has your company ever sponsored at least one phase I clinical trial?
  □ No
  □ Yes

  Q2: Has your company ever sponsored at least one phase II clinical trial?
  □ No
  □ Yes

  Q3: Has your company ever sponsored at least one phase Ⅲ clinical trial?
  □ No
  □ Yes

  Q4: Does your company? (more than one answer allowed)
  □ conduct its own clinical trials
  □ has its clinical trials conducted by a government institution (e.g. CDC)
  □ hires a Contract Research Organization [CRO] to do that
  □ has done both
  □ not applicable

  Q5: Previously to being conducted the clinical trials sponsored by your company require: (more than one answer allowed)
  □ approval by local Ethics Committees (of the institutions/hospitals were the trials are going to be conducted)
  □ approval by a regional or federal Ethics Committee
  □ approval by SFDA


第 [1] [2] [3] [4] [5] [6] [7] [8] 页 共[9]页
上面法规内容为部分内容,如果要查看全文请点击此处:查看全文
【发表评论】 【互动社区】
 
相关文章